CX Institutional’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$460K Sell
1,183
-303
-20% -$118K 0.02% 389
2025
Q1
$646K Buy
1,486
+622
+72% +$270K 0.02% 328
2024
Q4
$319K Sell
864
-526
-38% -$194K 0.01% 426
2024
Q3
$723K Sell
1,390
-12,451
-90% -$6.47M 0.03% 325
2024
Q2
$7.5M Buy
13,841
+12
+0.1% +$6.5K 0.35% 71
2024
Q1
$7.17M Buy
13,829
+5,105
+59% +$2.65M 0.35% 73
2023
Q4
$4.11M Sell
8,724
-4,435
-34% -$2.09M 0.22% 122
2023
Q3
$5.73M Buy
13,159
+466
+4% +$203K 0.32% 83
2023
Q2
$5.64M Buy
12,693
+1,899
+18% +$844K 0.29% 95
2023
Q1
$5.1M Buy
10,794
+9,592
+798% +$4.54M 0.27% 103
2022
Q4
$616K Buy
1,202
+242
+25% +$124K 0.04% 342
2022
Q3
$436K Sell
960
-5,443
-85% -$2.47M 0.03% 353
2022
Q2
$3.09M Buy
6,403
+753
+13% +$363K 0.23% 106
2022
Q1
$2.78M Buy
5,650
+4,861
+616% +$2.39M 0.22% 122
2021
Q4
$366K Sell
789
-3,729
-83% -$1.73M 0.03% 267
2021
Q3
$1.68M Buy
4,518
+3,712
+461% +$1.38M 0.14% 168
2021
Q2
$308K Sell
806
-118
-13% -$45.1K 0.03% 294
2021
Q1
$332K Sell
924
-5,161
-85% -$1.85M 0.03% 253
2020
Q4
$1.95M Sell
6,085
-909
-13% -$292K 0.19% 156
2020
Q3
$1.88M Sell
6,994
-3,679
-34% -$988K 0.2% 135
2020
Q2
$2.8M Buy
10,673
+1,314
+14% +$345K 0.37% 60
2020
Q1
$2.13M Buy
9,359
+6,748
+258% +$1.53M 0.35% 67
2019
Q4
$789K Buy
2,611
+2,567
+5,834% +$776K 0.14% 126
2019
Q3
$11K Sell
44
-64
-59% -$16K ﹤0.01% 447
2019
Q2
$30K Buy
108
+26
+32% +$7.22K ﹤0.01% 365
2019
Q1
$24K Buy
82
+48
+141% +$14K ﹤0.01% 389
2018
Q4
$9K Sell
34
-176
-84% -$46.6K ﹤0.01% 358
2018
Q3
$58K Hold
210
0.02% 175
2018
Q2
$50K Buy
+210
New +$50K 0.02% 161